- Ohio-based pharmaceutical company Cardinal Health will pay more than $8 million to resolve charges it violated the books, records and internal accounting controls provisions of the Foreign Corrupt Practices Act, the SEC announced Monday.
- Cardinal’s internal accounting controls were insufficient to detect improper payments made by employees of its former Chinese subsidiary, the SEC said.
via SEC hits Cardinal Health with accounting violations | CFO Dive.
